This week an expert panel presented data from the ESMO 2021 Congress in GI cancers, and discussed the impacts for Australian practice.

If you didn’t catch the webinar, you can watch on demand here:

Chaired by Professor Eva Segelov
Professor/Director of Oncology, Monash Health and Monash University; Board Member, Australasian Gastrointestinal Trials Group (AGITG), 2014–2020; Co-Founder, Commonwealth Neuroendocrine Tumour Collaboration (CommNETS).

PANEL

Dr Chris Jackson. Medical Oncologist, Mercy Cancer Care, Dunedin, and Clinical Lead for Oncology Research, Dunedin Hospital, New Zealand.

Associate Professor Adnan Nagrial. Medical Oncologist, Westmead and Blacktown Hospitals; Clinical Associate Professor, Sydney Medical School, The University of Sydney, NSW.

Professor Jeanne Tie. Lower GI Medical Oncologist, Peter MacCallum Cancer Centre and Western Health; Senior Research Fellow, Walter and Eliza Hall Institute of Medical Research, VIC.

This event was created independently by the limbic in collaboration with the host and presenters. All studies were selected by the presenters, and all views expressed were those of the host and presenters only. Thank you to our sponsors for providing the non-restrictive educational sponsorship that made this program possible.